vibegron [extracellular region]

Stable Identifier
R-ALL-9624761
Type
ChemicalDrug
Compartment
extracellular region
Locations in the PathwayBrowser
for Species:
Expand all
Literature References
PubMed ID Title Journal Year
26709102 Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder

Zamlynny, B, Morriello, G, Jochnowitz, N, Sanfiz, A, Stevenson, AS, Berger, R, Dingley, K, Ha, S, Villa, K, Sacre-Salem, B, Edmondson, SD, Fitzmaurice, A, Di Salvo, J, Ball, R, Hurley, AL, Kar, NF, Moyes, CR, Green, S, Zhu, C, Weber, AE, Goble, SD, Frenkl, T, Salituro, GM, Mistry, S, Shen, DM, Nagabukuro, H, Ormes, J, Harper, B, Struthers, M, Wang, L, Miller, RR, Levorse, D, Gichuru, LN

J. Med. Chem. 2016
29366513 Vibegron, a Novel Potent and Selective β3-Adrenoreceptor Agonist, for the Treatment of Patients with Overactive Bladder: A Randomized, Double-blind, Placebo-controlled Phase 3 Study

Gotoh, M, Kurose, T, Takeda, M, Yoshida, M, Nagai, S

Eur. Urol. 2018
29752752 Long-term safety and efficacy of the novel β3 -adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study

Kakizaki, H, Kurose, T, Takahashi, S, Yoshida, M, Nagai, S

Int. J. Urol. 2018
External Reference Information
External Reference
vibegron [Guide to Pharmacology:10100]
Participates
as a member of
Disease
Name Identifier Synonyms
bladder disease DOID:365 Urinary Bladder Disease
Cross References
ChEBI
Cite Us!